Chun Yang

Chun Yang


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 April 2019 in BioMed Research International
Verified
Journal Article
Open access
PDF file
JWJiawei Wei
Jiawei Wei
NLNan Lu
Nan Lu
ZLZhiying Li
Zhiying Li
XWXuanyan Wu
Xuanyan Wu
TJTao Jiang
Tao Jiang
SGShuliang Guo
Shuliang Guo
Tuberculosis remains one of the leading causes of death worldwide. Even if new antitubercular drugs are currently being developed, the rapid emergence and spread of drug-resistant strain remain a severe challenge. The CRISPR associated proteins 1 (Cas1), a most conserved endonuclease which is responsible for spacer integration into CRISPR arrays, was found deleted in many specific drug-resistant strains. The function of Cas1 is still unknown in Mycobacterium type III-A CRISPR family. In this study, the Cas1 (Rv2817c) defect was found in 57.14% of clinical isolates. To investigate the function of Cas1 in new spacer acquisition, we challenged Bacillus Calmette–Guérin (BCG) with a mycobacteriophage D29. Newly acquired spacer sequence matches D29 genome was not found by spacer deep-sequencing. We further expressed Cas1 in recombinant Mycobacterium smegmatis. We found that Cas1 increased the sensitivity to multiple anti-tuberculosis drugs by reducing the persistence during drug treatment. We also showed that Cas1 impaired the repair of DNA damage and changed the stress response of Mycobacterium smegmatis. This study provides a further understanding of Cas1 in Mycobacterium tuberculosis complex (MTBC) drug-resistance evolution and a new sight for the tuberculosis treatment.

1 January 2017 in BioMed Research International
Verified
Journal Article
Open access
PDF file
YHY. Hu
Y. Hu
LXLei Xu
Lei Xu
YHY. L. He
Y. L. He
YPY. Pang
Y. Pang
NLN. Lu
N. Lu
CYChun Yang
Chun Yang
This study aimed to investigate the prevalence of multidrug-resistant tuberculosis (MDR-TB) isolates resistant to the second-line antituberculosis drugs (SLDs) and its association with resistant-related gene mutations inMycobacterium tuberculosis(M.tb) isolates from Southwest of China. There were 81 isolates resistant to at least one of the SLDs among 156 MDR-TB isolates (81/156, 51.9%). The rates of general resistance to each of the drugs were as follows: OFX (66/156, 42.3%), KAN (26/156, 16.7%), CAP (13/156, 8.3%), PTO (11/156, 7.1%), PAS (22/156, 14.1%), and AMK (20/156, 12.8%). Therefore, the most predominant pattern was resistant to OFX compared with other SLDs (P<0.001). The results of sequencing showed that 80.2% OFX-resistant MDR-TB isolates containedgyrAmutation and 88.5% KAN-resistant isolates hadrrsmutations with the most frequent mutation being A1401G. These results suggest that improper use of SLDs especially OFX is a real threat to effective MDR-TB treatment not only in China but also in the whole world. Furthermore the tuberculosis control agencies should carry out SLDs susceptibility testing and rapid screening in a broader population of TB patients immediately and the SLDs should be strictly regulated by the administration in order to maintain their efficacy to treat MDR-TB.

1 February 2018 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
JYJie Yang
Jie Yang
BLBianbian Li
Bianbian Li
XLXiaoying Liu
Xiaoying Liu
HTHong Tang
Hong Tang
XZXiyao Zhuang
Xiyao Zhuang
CYChun Yang
Chun Yang

1 May 2014 in Human Immunology
Verified
Journal Article
Closed access
ZDZhiling Dong
Zhiling Dong
LXLei Xu
Lei Xu
JYJing YANG
Jing YANG
YHYonglin He
Yonglin He
QSQian She
Qian She
CYChun Yang
Chun Yang

1 October 2016
Verified
Journal Article
Closed access
CFChencheng Fang
Chencheng Fang
JZJiming Zhang
Jiming Zhang
NLNan Lu
Nan Lu
PLPeng Li
Peng Li
YFYu Fan
Yu Fan
YHYonglin He
Yonglin He